share_log

丰原药业(000153.SZ)：低钙腹膜透析液(乳酸盐-G1.5%)和低钙腹膜透析液(乳酸盐-G2.5%)获得药品注册证书

Fengyuan Pharmaceutical (000153.SZ): Low calcium peritoneal dialysis solution (lactate-G 1.5%) and low calcium peritoneal dialysis solution (lactate-G 2.5%) obtained drug registration certificates

Gelonghui Finance ·  May 10 05:21

Gelonghui, May 10, 丨 Fengyuan Pharmaceutical (000153.SZ) announced that recently, the company received the “Drug Registration Certificate” (certificate number: 2024S00742) for the low-calcium peritoneal dialysate (lactate-G 2.5%) and the “Drug Registration Certificate” (certificate number: 2024S00741) and low-calcium peritoneal dialysis solution (lactate-G 1.5%) approved and issued by the State Drug Administration.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment